Breast Cancer Connect
  • Saved

Prognostic value of molecular classification in metastatic breast cancer confirmed

Prognostic value of molecular classification in metastatic breast cancer confirmed

Source : https://www.eurekalert.org/pub_releases/2021-03/uob-pvo032921.php

Barcelona researchers at the Hospital Clínic-IDIBAPS Research Institute, the University of Barcelona and the SOLTI academic cancer research group have shown that the molecular classification of breast cancer, which divides...

  • Saved

Breast Cancer Patients: A Population-Based Analysis

Source : https://www.liebertpub.com/doi/10.1089/whr.2020.0094

If the address matches an existing account you will receive an email with instructions to reset your password.

  • Saved

Management of Abemaciclib‐Associated Adverse Events in Patients with Hormone Receptor‐Positive, Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3

Management of Abemaciclib‐Associated Adverse Events in Patients with Hormone Receptor‐Positive, Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3

Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794176/

Abemaciclib demonstrated efficacy in hormone receptor‐positive, human epidermal growth factor receptor 2‐negative advanced breast cancer. Here we provide a comprehensive summary of the most common adverse events (AEs), their management,...

  • Saved

Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2‐ advanced breast cancer: MONARCH 2 & 3 trials

Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2‐ advanced breast cancer: MONARCH 2 & 3 trials

Source : https://onlinelibrary.wiley.com/doi/10.1111/cas.14877

This post‐hoc analysis of MONARCH 2 and MONARCH 3 assesses the efficacy, safety, and pharmacokinetics (PK) of abemaciclib in combination with endocrine therapy (ET) in East Asian patients with hormone...

  • Saved

Detonating fuse for breast cancer discovered

Detonating fuse for breast cancer discovered

Source : https://eurekalert.org/pub_releases/2021-03/mdcf-dff032221.php

Targeted treatment of basal-like breast cancer could be facilitated by YAP inhibitors in the future. As reported by an MDC team headed by Walter Birchmeier in the scientific journal Cancer...